Arkolith/Insider Trading/RLAY/Form 4

Patel Sanjiv

President and CEO, DirectorRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jan 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$338K
Net Open-Market Flow
-$338K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2026Sell(S)43K$7.82$338K661K
Dec 31, 2025Grant(A)994$2.99$3K704K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-006328) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML